APP and Alzheimer disease: Another in vivo study using an AD mouse model (APP/PS1 mice) discovered that triptolide (20 g/kg intraperitoneally for 15 weeks) effectively reduced TNF-α and IL-1β production and restricted the activation of microglia towards the pro-inflammatory M1 state.